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ABSTRACT: A series of polysaccharide-based chiral stationary phase
(CSP) columns, Daicel Chiralpak IA, IB, and IC, were applied in the
separation of the nonenantiomeric isomers of various organometallic
compounds and were found to be highly eﬀective in recognizing isomers
of minor structural diﬀerences. The CSP columns have succeeded to
separate the double-bond regioisomers in bridged (η5-
formylcyclopentadienyl)manganese(I) dicarbonyl complexes 1a/1b,
the structural isomers of methylbutenylferrocene derivatives in 2a/2b
and 3a/3b, and the geometrical isomers of the (2-methyl-2-butenyl)-
ferrocenes in (Z)/(E)-3b. Due to the close similarity of the isomeric
compounds in these mixtures, separations of the components are
extremely diﬃcult and could not be attained by conventional methods such as silica gel column chromatography, silica gel
HPLC, recrystallization, distillation/sublimation, etc. Clearly, the polysaccharide-based CSP columns have unique advantages in
separation/puriﬁcation technology, and this study has shown potential usefulness of the CSP columns in separation of not only
enantiomeric but also nonenantiomeric mixtures.
■ INTRODUCTION
Organometallic reagents/catalysts are powerful tools for
making carbon−carbon bonds and have been utilized in
various transformations in modern organic synthesis. Although
the metal-mediated/catalyzed reactions have enhanced eﬃ-
ciency of organic synthesis, an apparent drawback of their use
is the occasional formation of undesirable isomerized side-
products. Unfortunately, however, these isomerized side-
products are chemically/structurally/functionally very similar
to the main products in many cases, and thus, their removal
(separation) from the target compounds are often problematic.
“High-performance liquid chromatography with chiral sta-
tionary phase (HPLC−CSP)” is a modern chromatographic
technology rapidly developing for enantiomeric resolution of
racemic (or scalemic) chiral compounds.1,2 Whereas the
supply of chiral compounds in enantiomerically pure forms
has been highly desirable in ﬁne chemical industries, the
HPLC−CSP technique has played an integral role in the
enantiomeric puriﬁcation of racemic/scalemic mixtures.
Among various CSP reported so far, polysaccharide-based
CSP columns are one of the most successful CSP families in
the chiral HPLC and show excellent performance in
enantiomeric resolution of a wide range of chiral molecules.3,4
During the course of our studies on various asymmetric
reactions, we have experienced that the polysaccharide-based
CSP columns are good at recognizing not only enantiomeric
pairs in chiral molecules but also closely related nonenantiomeric
isomers of minor structural dif ferences.5,6 Indeed, it was found
that the isomeric mixtures of organometallic complexes shown
in Figure 1 could be eﬃciently separated/puriﬁed by the use of
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Figure 1. Nonenantiomeric isomeric pairs of organometallic
complexes 1a/1b, 2a/2b, and 3a/3b examined in this report.
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the polysaccharide-based CSP columns developed by Daicel
Corporation.7 It is worth noting that separations of isomeric
pairs 1a/1b, 2a/2b, and 3a/3b by rather classical methods,
such as silica gel column chromatography, silica gel HPLC,
recrystallization, distillation/sublimation, etc., have been nearly
impossible due to the close similarity between the main and
the side products. Here we report details of the three examples
of the uses of the HPLC−CSP systems for puriﬁcation of the
organometallic compounds contaminated with the non-
enantiomeric isomers. This report demonstrates the potential
usefulness of the polysaccharide-based HPLC−CSP in
puriﬁcation/separation processes beyond the enantiomeric
resolution.
■ RESULTS AND DISCUSSION
Example 1: Separation of Double-Bond Regioisomers
1a and 1b in Bridged (η5-Formylcyclopentadienyl)-
manganese(I) Complexes. In 2017, we reported the
synthesis of planar-chiral bridged (η5-formylcyclopentadienyl)-
manganese(I) dicarbonyl complex (R)-1a by the reaction
shown in Scheme 1.8 The bromo-substituent in (R)-4 was
lithiated by the lithium−bromine exchange reaction using
tBuLi, and a following reaction with DMF provided (R)-1a in
variable yield ranging 32−80%. The variable yield in this
reaction could be partly ascribed to the formation of
undesirable double-bond regioisomer (R)-1b. The methylene
hydrogens in the bridging Ph2PCH2CMeCH-moiety in (R)-
4 are somewhat acidic, and an isomerization of the CC
double bond to an adjacent position took place under the basic
conditions via a deprotonation/protonation sequence to give
(R)-1b as a contaminant (Scheme 1). The mixture of (S)-1a
and (S)-1b was prepared from (S)-4 in the same way.
Removal of (R)-1b from crude (R)-1a was found to be very
diﬃcult. The two compounds are isomeric to each other with
very similar three-dimensional structures. Both (R)-1a and
(R)-1b also possess identical sets of polar functional groups
including formyl, diphenylphosphino, and manganese(I)
dicarbonyl groups. Classical chromatographic methods such
as silica gel column chromatography, HPLC with a silica gel
stationary phase, and preparative gel permeation chromatog-
raphy, are all ineﬀective in separating the two compounds.
Recrystallization of the crude mixture of (R)-1a and (R)-1b
from hexane/ethyl acetate aﬀorded yellow solid in which the
two compounds cocrystallized, and isolation of pure (R)-1a
could not be attained.
It was found that the polysaccharide-based CSP columns
were highly eﬀective in separating the two compounds. Figure
2 shows the HPLC chromatograms of the mixture of (R)-1a
and (R)-1b on Daicel Chiralpak IA, IB, or IC using hexane/
ethyl acetate (2/1) as an eluent. An HPLC chromatogram on a
standard silica gel column (Tosoh TSKgel Silica-150) is also
displayed for comparison. The silica gel stationary phase did
not recognize the structural diﬀerence between (R)-1a and
(R)-1b, and the analysis of the mixture on it showed a single
sharp peak as in Figure 2(a). Among the three chiral columns
examined, Chiralpak IA showed the most eﬀective separation
of the two compounds (Figure 2(b)). Under the analysis
conditions (column length: 250 mm; column i.d.: 4.6 mm;
eluent: hexane/ethyl acetate = 2/1; ﬂow rate: 0.5 mL/min;
injection: ca. 10 μg in 10 μL), (R)-1a and (R)-1b were
detected at 21.3 and 10.9 min, respectively, and the resolution
factor (Rs)9 for this analysis reached to 19.0. The mixture of
(R)-1a and (R)-1b was also well-recognized on Chiralpak IB,
and clear separation of the two components was realized with
the Rs value of 3.88 (Figure 2(c)). Chiralpak IC also gave the
two peaks on the HPLC analysis of the mixture; however, only
the partial separation could be attained under the given
conditions (Rs = 1.07).
The HPLC separation of (R)-1a and (R)-1b could be
conducted on a semimacro scale as well. A sample of the
mixture of (R)-1a and (R)-1b (1a/1b = 3/1; ca. 25 mg in 2
mL of the hexane/ethyl acetate eluent) was separated cleanly
on Chiralpak IA (250 mm × 20 mm i.d.). The mixture of (R)-
1a and (R)-1b (1a/1b = 3/1; 106 mg) was divided into ﬁve
aliquots, and each aliquot was subjected to the HPLC−CSP
separation on Chiralpak IA as above. After the ﬁve-time
HPLC−CSP runs, (R)-1a (72 mg; 68%) and (R)-1b (23 mg;
22%) were obtained in pure forms.
It should be noted that the amount of the sample injection
was regulated by the solubility of the mixture in the eluent (the
injected solution was already saturated in the present eluent),
and sample loading may be increased by the use of a proper
(i.e., more soluble) solvent.
Scheme 1. Preparation of (R)-1a with Plausible Pathways to
Contaminant (R)-1b
Figure 2. HPLC traces for the mixture of (R)-1a (●) and (R)-1b (○)
on silica gel column (a), Daicel Chiralpak IA (b), Daicel Chiralpak IB
(c), and Daicel Chiralpak IC (d) using hexane/ethyl acetate = 2/1 as
an eluent. Column length: 250 mm; column i.d.: 4.6 mm; ﬂow rate:
0.5 mL/min; injection: ca. 10 μg in 10 μL.
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Whereas complexes 1a/1b are planar-chiral, the HPLC
separation of the 1a/1b mixture of the enantiomeric antipodes,
that is the mixture of (S)-1a and (S)-1b, on the CSP columns
was also examined. The results are summarized in Figure 3
with an HPLC chromatogram on the silica gel column for
comparison. Daicel Chiralpak IA, IB, and IC all showed good
to fair recognition between (S)-1a and (S)-1b with the Rs
values of 2.37, 1.87, and 1.08, respectively. The separation of
(S)-1a and (S)-1b are, however, relatively less eﬀective than
that of the (R)-isomers on Chiralpak IA or Chiralpak IB,
because these two CSP columns recognize not only double-
bond regioisomers 1a/1b but also the planar-chiral enantio-
meric pairs in 1a and 1b as well. As envisaged by the results
shown in Figures 2 and 3, the HPLC−CSP traces for the
mixture of rac-1a and rac-1b showed the partially overlapped
four or three peaks by the simultaneous enantiomeric
resolution of the respective planar-chiral enantiomers and the
isomeric separation (see Supporting Information). Never-
theless, these results clearly demonstrate the potential
usefulness of the polysaccharide-based CSP columns for the
separation of the double-bond regioisomers.
Examples 2 and 3: Separation of Ferrocene Deriva-
tives 2a/2b and 3a/3b Having Isomeric Methylbutenyl
Substituents. Reaction between 1,1′-dibromoferrocene and
excess (3-methyl-3-butenyl)magnesium bromide was con-
ducted in the presence of PEPPSI-IPr10 catalyst (5.0 mol %).
The Kumada−Tamao−Corriu coupling of the ferrocene-
electrophile was fairly slow, and monoalkenylated species 3a
was obtained predominantly together with minor side-products
3b and recovered 1,1′-dibromoferrocene. Due to the slowness
of the coupling reaction, the formation of 1,1′-dialkenylferro-
cene was very minor. The structures of 3b could not be
determined at this stage, because 3b was inseparable from 3a
by standard silica gel column chromatography. The crude
mixture of 3a and 3b was used in the subsequent reactions
without separation, and they were converted into rac-2a and
rac-2b, respectively (see, Experimental Section for details).
Whereas the mixture of rac-2a and rac-2b was also inseparable
by the classical methods (silica gel-based chromatography,
GPC, etc.), the HPLC−CSP systems were examined in the
separation of the two species. And indeed, they were found to
be quite powerful (vide infra). After the separation of rac-2b
from rac-2a, the identity of rac-2b was clariﬁed to be a mixture
of (Z)- and (E)-1-bromo-1′-(2-methyl-2-butenyl)ferrocene by
the 1H and 13C NMR measurements as well as by the MS
analysis (Figure 1 and Scheme 2). And eventually, the
structure of 3b was determined as depicted. It is worth
mentioning that the observed “3-methyl-3-butenyl” to “2-
methyl-2-butenyl” isomerization in the palladium-catalyzed
cross-coupling reaction is unique to the bromoferrocene
electrophile; an analogous reaction between bromobenzene
and (3-methyl-3-butenyl)magnesium bromide provided (3-
methyl-3-butenyl)benzene exclusively under otherwise identi-
cal conditions and isomerized products were not detected.
Figure 3. HPLC traces for the mixture of (S)-1a (●) and (S)-1b (○)
on silica gel column (a), Daicel Chiralpak IA (b), Daicel Chiralpak IB
(c), and Daicel Chiralpak IC (d) using hexane/ethyl acetate = 2/1 as
an eluent. Column length: 250 mm; column i.d.: 4.6 mm; ﬂow rate:
0.5 mL/min; injection: ca. 10 μg in 10 μL.
Scheme 2. Preparation of rac-2a and rac-2b with Plausible Pathways to 3b
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The formation of 3b is rationalized as shown in Scheme 2.
Palladium intermediate A, which is formed via the oxidative
addition of 1,1′-dibromoferrocene to the Pd(0) species
followed by the transmetalation with the Grignard reagent,
undergoes two modes of transformations. One is the direct
reductive elimination to give 3a (the major pathway), and the
other is isomerization to intermediate C by the β-hydride
elimination of 3-methyl-3-butenyl substituent and the follow-
ing reverse insertion of generated η2-isoprene to the
palladium(II)-hydride bond in intermediate B. Subsequently,
an allylic rearrangement from C to D followed by the reductive
elimination from D gives the mixture of (Z)- and (E)-3b as the
side-products.11
Compounds rac-2a/rac-2b are liquid and noncrystalline, and
thus they could not be puriﬁed by recrystallization. Rather
classical chromatographic methods, which included silica gel
column chromatography, HPLC with a silica gel stationary
phase, and preparative GPC, all failed to separate rac-2b from
rac-2a. On the other hand, the polysaccharide-based CSP
columns showed good recognition between rac-2a and rac-2b.
Figure 4 shows the HPLC chromatograms of the mixture of
rac-2a and rac-2b. While the mixture was detected as a single
broad peak on the silica gel stationary phase as shown in Figure
4(a), Chiralpak IA and IB could separate rac-2b from rac-2a
(Figure 4(b,c)). The smaller “bimodal” peaks in Figure 4(b,c),
which were fast-eluting and detected at 11.2 min and at 13.0
min, respectively, were assigned to the (E)/(Z)-mixture of rac-
2b. The bimodal shape of the smaller peaks may be ascribed to
incomplete separation of the (E)- and (Z)-isomers on these
CSP columns. Alternatively, it can be explained as partial
enantiomeric resolution of planar-chiral and racemic rac-2b by
the chiral stationary phases in Chiralpak IA and IB. The main
component in the sample, rac-2a, is also planar-chiral and
racemic; however, the chiral recognition of the enantiomeric
pair in rac-2a by Chiralpak IA and IB was negligible under the
employed conditions, and their enantiomeric resolution was
not practical with these columns. On the other hand, Chiralpak
IC gave the partially overlapped four peaks on the HPLC
analysis of the rac-2a/rac-2b mixture, which could be ascribed
to the concurrent enantiomeric resolution of planar-chiral rac-
2a/rac-2b and the isomeric separation between the two. The
crude mixture of rac-2a and rac-2b (2a/2b = ca. 85/15; 83.5
mg in 2 mL of hexane) was separated on semimacro scale
Chiralpak IA (250 mm × 20 mm i.d.), and rac-2a (64.0 mg;
76.6%) and rac-2b (10.4 mg; 12.5%) were obtained.
After the successful removal of rac-2b from rac-2a, validity of
the chiral HPLC columns for the separation of 3a and 3b was
also examined. Ferrocene derivatives 3a and 3b are both liquid
and could not be puriﬁed by recrystallization. While the
classical chromatographic methods (silica gel column chroma-
tography, HPLC with a silica gel stationary phase, and
preparative GPC) were all ineﬀective in separating 3a and
3b, Daicel Chiralpak IA, IB, and IC all showed good to fair
recognition between 3a and 3b. Figure 5 shows the HPLC
chromatograms of the mixture of 3a and 3b on Daicel
Chiralpak IA, IB, or IC using hexane as an eluent. An HPLC
chromatogram on the silica gel column is also shown for
comparison (Figure 5(a)). While Chiralpak IB could achieve
only partial separation of 3a and 3b (Figure 5(c)), both
Chiralpak IA and IC succeeded in separating the mixture.
Chiralpak IC gave the two peaks on the HPLC analysis of the
3a/3b mixture (Rs = 1.14; Figure 5(d)), and the fast-eluting
smaller peak at 12.5 min was found to be a mixture of (Z)- and
(E)-3b. On the other hand, the analysis on Chiralpak IA
provided three peaks at 10.4, 11.2, and 12.0 min, respectively,
Figure 4. HPLC traces for the mixture of rac-2a (●) and rac-2b (○)
on silica gel column (a), Daicel Chiralpak IA (b), Daicel Chiralpak IB
(c), and Daicel Chiralpak IC (d) using hexane/ethyl acetate = 2/1
(for the silica gel column) or hexane (for the CSP columns) as an
eluent. Column length: 250 mm; column i.d.: 4.6 mm; ﬂow rate: 0.5
mL/min; injection: ca. 10 μg in 10 μL.
Figure 5. HPLC traces for the mixture of 3a (●), (Z)-3b (○), and
(E)-3b (◎) on silica gel column (a), Daicel Chiralpak IA (b), Daicel
Chiralpak IB (c), and Daicel Chiralpak IC (d) using hexane/ethyl
acetate = 2/1 (for the silica gel column) or hexane (for the CSP
columns) as an eluent. Column length: 250 mm; column i.d.: 4.6 mm;
ﬂow rate: 0.5 mL/min; injection: ca. 10 μg in 10 μL.
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and the second and the third peaks overlapped partially
(Figure 5(b)).
The identity of the three peaks in Figure 5(b) was clariﬁed
to be (Z)-3b, (E)-3b, and 3a, respectively, by the two
successive HPLC−CSP separations of the mixture and the 1H
and 13C NMR/LR-MS measurements of the separated
fractions (Scheme 3). The semimacro scale preparative
HPLC of the 3a/3b mixture on Chiralpak IC (250 mm ×
20 mm i.d.) aﬀorded pure 3a in 76.9% and the mixture of (Z)-
and (E)-3b, and the latter was further separated into the two
components in 10.5% and 4.1%, respectively, by the
preparative HPLC on Chiralpak IA (250 mm × 20 mm i.d.).
Figure 6 shows the HPLC chromatograms of the mixture of
(Z)- and (E)-3b on the silica gel column and on Chiralpak IA,
IB, and IC. Contrary to Chiralpak IA, both Chiralpak IB and
IC failed in separating (Z)- and (E)-3b.
■ CONCLUSIONS
In this article, we have demonstrated that the polysaccharide-
based CSP columns, namely Daicel Chiralpak IA, IB, and IC,
are highly eﬀective in separating closely related nonenantio-
meric isomers. The CSP columns have succeeded to recognize
the double-bond regioisomers in 1a/1b, the structural-isomeric
methylbutenyl side-arms in 2a/2b and 3a/3b, and the
geometrical isomers in (Z)/(E)-3b. Due to the close similarity
of the isomeric compounds in these mixtures, separations of
the components are extremely diﬃcult and could not be
attained by the rather classical methods such as silica gel
column chromatography, silica gel HPLC, recrystallization,
distillation/sublimation, etc. Clearly, the polysaccharide-based
CSP columns have unique advantages in separation/
puriﬁcation technology, and this study has shown potential
usefulness of the CSP columns in separation of not only
enantiomeric but also nonenantiomeric mixtures.
The “ﬁrst-generation” polysaccharide-based CSPs, which
have been on the market since the 1980s, are prepared by
coating the polysaccharide derivatives on a macroporous silica
gel. The coated-type CSPs have severe limitations in the
selection of eluents. In general, hexane, ethanol, 2-propanol,
and their mixtures are the only solvents applicable on the
normal phase coated-type CSP columns (the reverse phase
CSP columns, which can be used with water/methanol/
acetonitrile, are also available from Daicel Corporation). On
the other hand, the polysaccharide derivatives are immobilized
on a silica gel support in the CSP columns used in this study.3e
The immobilized-type CSP columns, which have been
commercialized since 2004, are much more durable and can
be used with various eluents.12 The robustness of the
immobilized-type CSP columns makes them more user-
friendly and should enhance their uses beyond the
enantiomeric separation.
■ EXPERIMENTAL SECTION
General Information. All anaerobic and/or moisture sensitive
manipulations were carried out with standard Schlenk techniques
under predried nitrogen or with glovebox techniques under
prepuriﬁed argon. 1H NMR (at 400 MHz) and 13C NMR (at 100
MHz) chemical shifts are reported in ppm downﬁeld of internal
tetramethylsilane. 31P NMR (at 162 MHz) chemical shifts are
externally referenced to 85% H3PO4. Tetrahydrofuran was distilled
from benzophenone-ketyl under nitrogen prior to use. (R)- or (S)-
[(η5-1-Bromo-2-(3-diphenylphosphino-2-methylpropenyl)-cyclopen-
tadienyl-P)]manganese(I) dicarbonyl ((R)- or (S)-4),8 1,1′-dibromo-
ferrocene,13 and 4-bromo-2-methylbutene14 were prepared according
to the reported methods. All the other chemicals were obtained from
commercial sources and used as received unless otherwise noted. The
CSP columns (Chiralpak IA, IB, and IC) were purchased from Daicel
Corporation (Tokyo, Japan).12 The silica gel column (TSKgel Silica-
150) was purchased from Tosoh Corporation (Tokyo, Japan).
Instrumentation and HPLC−CSP Conditions. Chromato-
graphic studies on the CSPs were performed with a JASCO PU-
2086 (pump)/UV-2075 (UV detector) system at room temperature.
The eluents were speciﬁed in the legends of the chromatograms
(Figures 2−6). The ﬂow rate was 0.5 mL/min (on the analytical
columns; 250 mm-length/4.6 mm-i.d.) or 9.5 mL/min (on the
semimacro scale columns; 250 mm-length/20 mm-i.d.), and the
detection wavelength was 254 nm.
Preparation of 1a/1b Mixture. To a solution of (R)-(−)-4 (94.1
mg, 0.191 mmol) in THF (2 mL) was added tBuLi (1.62 M in
Scheme 3. Separation of 3a, (Z)-3b, and (E)-3b by
Successive Preparative HPLC on Chiralpak IC and
Chiralpak IA
Figure 6. HPLC traces for the mixture of (Z)-3b (○) and (E)-3b
(◎) on silica gel column (a) and Daicel Chiralpak IA (b), Daicel
Chiralpak IB (c), and Daicel Chiralpak IC (d) using hexane/ethyl
acetate = 2/1 (for the silica gel column) or hexane (for the CSP
columns) as an eluent. Column length: 250 mm; column i.d.: 4.6 mm;
ﬂow rate: 0.5 mL/min; injection: ca. 10 μg in 10 μL.
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pentane, 0.30 mL, 0.486 mmol) dropwise at −78 °C. After stirring the
solution for 1 h at −78 °C, DMF (21 mg, 0.29 mmol) was added
dropwise, then the resulting mixture was gradually warmed to room
temperature. The resulting solution was quenched with aqueous
NH4Cl solution and the mixture was extracted with EtOAc. The
combined organic layer was washed with brine and dried over
anhydrous MgSO4. The mixture was ﬁltrated and concentrated under
reduced pressure. The residue was puriﬁed by a silica gel
chromatography (hexane/EtOAc = 3/1) to give a mixture of (R)-
1a and (R)-1b as a yellow solid (70.1 mg, 0.159 mmol, 83%). The
molar ratio between the two isomers was determined to be (R)-1a/
(R)-1b = 3/1 by the 31P NMR measurement. The mixture of (S)-1a
and (S)-1b was prepared in the same way starting with (S)-(+)-4. The
(R)- or (S)-1a/1b mixtures were used for the HPLC−CSP studies
without further puriﬁcations.
(R)-(+)-[(η5-1-(3-Diphenylphosphino-2-methyl-1-propenyl)-
cyclopentadienyl-2-formyl-P)]manganese(I) Dicarbonyl (1a). 1H
NMR (CDCl3) δ 1.67 (s, 3H), 2.91−2.97 (m, 1H), 3.01−3.07 (m,
1H), 4.36 (br, 1H), 5.00 (br, 1H), 5.21 (br, 1H), 6.16 (br, 1H),
7.36−7.44 (m, 10H), 9.43 (s, 1H). 13C{1H} NMR (CDCl3) δ 27.3
(d, JPC = 4.2 Hz), 34.7 (d, JPC = 20.3 Hz), 80.4 (s), 80.8 (s), 83.7 (s),
87.2 (s), 103.3 (s), 115.6 (d, JPC = 12.0 Hz), 128.3 (d, JPC = 8.9 Hz),
128.4 (d, JPC = 8.8 Hz), 129.8 (s), 130.0 (s), 131.4 (d, JPC = 9.8 Hz),
131.7 (d, JPC = 10.2 Hz), 136.8 (d, JPC = 41.3 Hz), 137.5 (d, JPC =
42.8 Hz), 138.8 (s), 189.7 (s), 228.1 (d, JPC = 21.8 Hz), 229.3 (d, JPC
= 20.8 Hz). 31P{1H} NMR (CDCl3) δ 103.3 (s). ES-HRMS calcd for
C24H20MnO3P 442.0531, found 442.0538. [α]D
12 +344 (c 1.01,
CHCl3).
(R)-(+)-[(η5-1-(3-Diphenylphosphino-2-methyl-2-propenyl)-
cyclopentadienyl-2-formyl-P)]manganese(I) Dicarbonyl (1b). 1H
NMR (CDCl3) δ 2.15 (s, 3H), 2.85−2.89 (m, 1H), 3.36−3.40 (m,
1H), 4.50 (br, 1H), 4.75 (br, 1H), 5.13 (br, 1H), 6.26 (br, 1H),
7.36−7.45 (m, 10H), 9.40 (s). 13C{1H} NMR (CDCl3) δ 28.1(s),
29.3 (s), 79.9 (s), 82.9 (s), 84.5 (s), 85.9 (s), 102.6 (s), 117.8 (d, JPC
= 40.9 Hz), 128.3 (d, JPC = 10.2 Hz, 2C), 129.3 (s), 129.5 (s), 131.5
(d, JPC = 10.8 Hz), 131.8 (d, JPC = 10.7 Hz), 138.5 (d, JPC = 48.2 Hz),
139.3 (d, JPC = 47.7 Hz), 155.5 (d, JPC = 13.0 Hz), 189.3 (s), 228.4
(d, JPC = 22.0 Hz), 229.4 (d, JPC = 23.4 Hz).
31P{1H} NMR (CDCl3)
δ 74.4 (s). ES-HRMS calcd for C24H20MnO3P 442.0531, found
442.0535. [α]D
23 +38.5 (c 0.50, CHCl3).
Preparation of 3a/3b Mixture. To a solution of 1,1′-
dibromoferrocene (1.00 g, 2.91 mmol) and PEPPSI-IPr (99.0 mg;
0.146 mmol; 5 mol %) in THF (3 mL) was added a THF solution of
(3-methyl-4-butenyl)magnesium bromide, which was prepared from
4-bromo-2-methylbutene (1.73 g; 11.6 mmol) and magnesium
powder (290 mg; 11.9 mmol) in THF (5 mL), and the mixture
was stirred for 20 h at 40 °C. The reaction mixture was quenched with
a small amount of water at 0 °C, then the mixture was evaporated to
dryness under reduced pressure. The residue was ﬁltered through a
short pad of silica gel using hexane as an eluent. After removal of the
solvent, the crude material was chromatographed on silica gel (eluent:
hexane) to give a mixture of 3a and 3b (210 mg; 0.631 mmol; 22%)
as an orange oil together with recovered 1,1′-dibromoferrocene (420
mg, 1.22 mmol; 42%). The mixture of 3a and 3b was used for the
preparation of 2a/2b as well as for the HPLC−CSP studies without
further puriﬁcations.
1-Bromo-1′-(3-methyl-3-butenyl)ferrocene (3a). 1H NMR
(CDCl3) δ 1.76 (s, 3H), 2.22−2.26 (m, 2H), 2.47−2.51 (m, 2H),
4.04−4.05 (m, 2H), 4.08−4.09 (m, 2H), 4.11−4.12 (m, 2H), 4.30−
4.31 (m, 2H), 4.70−4.71 (m, 1H), 4.73−4.74 (m, 1H). 13C{1H}
NMR (CDCl3) δ 22.8, 27.2, 39.2, 67.7, 69.9, 70.7, 70.8, 78.3, 90.8,
110.2, 145.7. ES-HRMS calcd for C15H17BrFe: 331.9865, found
331.9869.
(E)-1-Bromo-1′-(2-methyl-2-butenyl)ferrocene ((E)-3b). 1H NMR
(CDCl3) δ 1.54 (d, J = 6.7 Hz, 3H), 1.56 (br s, 3H), 3.04(s, 2H),
4.04−4.05 (m, 2H), 4.07−4.08 (m, 2H), 4.12−4.13 (m, 2H), 4.30−
4.31 (m, 2H), 5.17 (qq, J = 6.7 and 1.3 Hz, 1H). 13C{1H} NMR
(CDCl3) δ 13.5, 16.0, 39.4, 67.8, 70.1, 70.9, 71.7, 78.4, 89.1, 119.1,
135.9. ES-HRMS calcd for C15H17BrFe 331.9865, found 331.9866.
(Z)-1-Bromo-1′-(2-methyl-2-butenyl)ferrocene ((Z)-3b). 1H NMR
(CDCl3) δ 1.61−1.62 (m, 3H), 1.67 (d, J = 6.87 Hz, 3H), 3.10 (s,
2H), 4.06−4.07 (m, 2H), 4.09−4.10 (m, 2H), 4.11−4.12 (m, 2H),
4.32−4.33 (m, 2H), 5.20 (q, J = 6.87 Hz, 1H). 13C{1H} NMR
(CDCl3) δ 13.7, 23.5, 31.0, 67.9, 70.0, 70.9, 71.5, 78.4, 89.3, 119.3,
135.6. ES-HRMS calcd for C15H17BrFe 331.9865, found 331.9870.
Preparation of 2a/2b Mixture. The mixture of 2a/2b was
prepared from the 3a/3b mixture by the two-step sequence as
outlined below.
A solution of 3a/3b mixture (854 mg, 2.56 mmol) in THF (2 mL)
was cooled to −30 °C, and to this was added a THF solution of
LTMP, which was prepared from 2,2,6,6-tetramethylpipperidine (400
mg, 2.83 mmol) and nBuLi (1.64 mol/L in hexane, 1.6 mL, 2.62
mmol) in THF (2 mL) at 0 °C, dropwise via a cannula. After stirring
the solution for 3 h at −30 °C, DMF (300 μL, 283 mg, 3.87 mmol)
was added using a syringe. The solution was warmed to room
temperature and stirred for 6 h. The reaction was quenched with
water, and then the products were extracted with dichloromethane.
The dichloromethane solution was dried over MgSO4, ﬁltered, and
evaporated to dryness. The residue was chromatographed on silica gel
(hexane/ethyl acetate = 10/1) to give a mixture of the formyl species
5 as a dark yellow oil. Yield: 491 mg (1.36 mmol, 53%). rac-1-Bromo-
2-formyl-1′-(3-methyl-3-butenyl)ferrocene (5). 1H NMR (C6D6) δ
1.62 (s, 3H), 2.00−2.04 (m, 2H), 2.21−2.25 (m, 2H), 3.82−3.89 (m,
5H), 4.26 (br, 1H), 4.62 (br, 1H), 4.75 (br, 1H), 4.78 (br, 1H), 10.23
(s, 1H). 13C{1H} NMR (C6D6) δ 22.6, 26.6, 39.0, 67.4, 71.52, 71.55,
71.8, 71.98, 72.01, 75.3, 76.6, 80.9, 92.5, 110.9, 144.9, 191.6. ES-
HRMS calcd for C16H17BrFeNaO (M + Na) 382.9710, found
382.9713.
A solution of Ph3PMe·Br (298 mg, 0.834 mmol) in THF (1 mL)
was cooled to 0 °C, and to this was added nBuLi (1.64 mol/L in
hexane, 0.51 mL, 0.836 mmol) using a syringe. After stirring the
solution for 30 min at 0 °C, a THF (1.5 mL) solution of 5 (200 mg,
0.556 mmol) was added via a cannula. The solution was warmed to
room temperature and stirred for 2 h. The reaction was quenched
with aqueous NaHCO3, then the products were extracted with ether.
The ether solution was dried over MgSO4, ﬁltered, and evaporated to
dryness. The residue was chromatographed on silica gel (hexane/
ether = 20/1) to give a mixture of 2a and 2b as a dark yellow oil.
Yield: 189 mg (0.526 mmol, 95%). The 2a/2b mixture was used for
the HPLC−CSP studies without further puriﬁcations.
rac-1-Bromo-1′-(3-methyl-3-butenyl)-2-vinylferrocene (rac-2a).
1H NMR (CDCl3) δ 1.75 (s, 3H), 2.18−2.21 (m, 2H), 2.40−2.45
(m, 2H), 3.98−3.99 (m, 2H), 4.04−4.06 (m, 2H), 4.17−4.18 (m,
1H), 4.38−4.39 (m, 1H), 4.41−4.42 (m, 1H), 4.69−4.70 (m, 1H),
4.72−4.73 (m, 1H), 5.21 (dd, J = 11.0 and 1.4 Hz, 1H), 5.45 (dd, J =
17.9 and 1.4 Hz, 1H), 6.56 (dd, J = 17.9 and 11.0 Hz, 1H). 13C{1H}
NMR (CDCl3) δ 22.7, 26.4, 38.9, 63.6, 67.4, 71.0, 71.1, 71.30, 71.31,
71.7, 80.1, 81.7, 90.9, 110.0, 113.0, 132.0, 145.6. ES-HRMS calcd for
C17H20BrFe (M + 1) 359.0098, found 359.0099.
rac-(E/Z)-1-Bromo-1′-(2-methyl-2-butenyl)-2-vinylferrocene
(rac-(E/Z)-2b). 1H NMR (CDCl3) δ 1.53 (d, J = 6.2 Hz, 3H of E-
isomer), 1.54 (s, 3H of E-isomer), 1.58−1.59 (m, 3H of Z-isomer),
1.65−1.67 (m, 3H of Z-isomer), 2.94 (br, 2H of E-isomer), 3.01 (br,
2H of Z-isomer), 3.96−3.98 (m, 2H of both isomers), 4.03−4.08 (m,
2H of both isomers), 4.16−4.17 (m, 1H of Z-isomer), 4.18−4.19 (m,
1H of E-isomer), 4.37−4.43 (m, 2H of both isomers), 5.12−5.20 (m,
1H of both isomers), 5.22 (dd, J = 10.5 and 1.4 Hz, 1H of Z-isomer),
5.23 (dd, J = 10.5 and 1.4 Hz, 1H of E-isomer), 5.45 (dd, J = 17.4 and
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1.4 Hz, 1H of Z-isomer), 5.48 (dd, J = 17.5 and 1.4 Hz, 1H of E-
isomer), 6.55 (dd, J = 17.4 and 10.5 Hz, 1H of Z-isomer), 6.58 (dd, J
= 17.5 and 10.5 Hz, 1H of E-isomer). 13C{1H} NMR (CDCl3) δ 13.5,
13.7, 15.9, 23.4, 30.4, 38.8, 63.81, 63.84, 67.66, 67.70, 71.16, 71.24,
71.3, 71.4, 71.5, 71.6, 72.2, 72.4, 72.7, 72.9, 80.20, 80.25, 81.88
(overlap of two peaks), 89.3, 89.5, 113.1, 113.2, 119.1, 119.2, 132.20,




The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acs.organo-
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